Thrombus Formation in Left Atrium on Dabigatran Therapy

Dabigatran is a direct thrombin inhibitor, approved in the United States for stroke prevention in nonvalvular atrial fibrillation and prevention and treatment of thromboembolism. It has been also used in patients with documented left atrial thrombus, where treatment with dabigatran effectively led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Priyank, Mithawala, Priyam, Konlian, Donna, Soyombo, Aderemi, Bikkina, Mahesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352418/
https://www.ncbi.nlm.nih.gov/pubmed/25793127
http://dx.doi.org/10.1155/2015/518982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352418/
https://www.ncbi.nlm.nih.gov/pubmed/25793127
http://dx.doi.org/10.1155/2015/518982

Ejemplares similares